Abstract
Purpose
The human pathophysiology of stunned, hibernating and scarred myocardium in ischemic cardiomyopathy is a subject of controversy. While the “smart heart” theory postulates that reduced myocardial blood flow (MBF) at rest is responsible for myocytes switching to a state of hibernation, other theories suggest that a reduced myocardial flow reserve (MFR) may be the cause.
Methods
We included 110 patients with ischemic cardiomyopathy. Based on quantitative myocardial perfusion assessment and viability imaging with 13N-NH3 and 18F-FDG positron emission tomography, respectively, as well as wall motion assessment from echocardiography, myocardial tissue was characterized as remote (i.e., normal myocardium), stunned (i.e., dysfunctional but viable myocardium with normal rest perfusion), hibernating (i.e., dysfunctional but viable myocardium with impaired rest perfusion), or scarred myocardium (i.e., non-viable myocardium).
Results
Compared to remote myocardium, dysfunctional but viable myocardium (including stunned and hibernating) had reduced rest MBF (0.89 mL/min/g vs. 0.79 and 0.76 mL/min/g, respectively; p < 0.001) and MFR (1.53 vs. 1.27 and 1.17; p < 0.001). Between stunned and hibernating myocardium, however, rest MBF and MFR did not differ (p = 0.40). In scarred myocardium, rest MBF was lowest (0.66 mL/min/g; p < 0.001) but, in contrast to the other myocardial states, k2 (i.e., tracer washout) was increased (0.199/min vs. 0.178/min to 0.181/min; all p < 0.05 in pairwise comparison).
Conclusions
In patients with ischemic cardiomyopathy, impaired MFR is associated with stunning and hibernation. These states of dysfunctional but viable myocardium have lower rest MBF compared to remote myocardium. At the end of the continuum, rest MBF is lowest in scar tissue and linked to increased rate of tracer washout.
Similar content being viewed by others
References
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200. https://doi.org/10.1093/eurheartj/ehw128.
Canty JM, Fallavollita JA. Chronic hibernation and chronic stunning: a continuum. J Nucl Cardiol. 2000;7:509–27. https://doi.org/10.1067/mnc.2000.109683.
Benz DC, Gaemperli O. The right timing for post-ischemic stunning. J Nucl Cardiol. 2017;24:1302–4.
Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211–21.
Camici PG, Wijns W, Borgers M, De Silva R, Ferrari R, Knuuti J, et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation. 1997;96:3205–14.
Vanoverschelde JL, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, et al. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation. 1993;87:1513–23.
Gerber BL, Vanoverschelde JL, Bol A, Michel C, Labar D, Wijns W, et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation. 1996;94:651–9.
Benz DC, Gräni C, Ferro P, Neumeier L, Messerli M, Possner M, et al. Corrected coronary opacification decrease from coronary computed tomography angiography: validation with quantitative 13N-ammonia positron emission tomography. J Nucl Cardiol. 2017. https://doi.org/10.1007/s12350-017-0980-2.
Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986;314:884–8. https://doi.org/10.1056/NEJM198604033141405.
Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol. 2009;54:150–6. https://doi.org/10.1016/j.jacc.2009.02.069.
Steffen DA, Giannopoulos AA, Grossmann M, Messerli M, Schwyzer M, Gräni C, et al. "apical thinning": relations between myocardial wall thickness and apical left ventricular tracer uptake as assessed with positron emission tomography myocardial perfusion imaging. J Nucl Cardiol. 2018. https://doi.org/10.1007/s12350-018-1397-2.
Ling LF, Marwick TH, Flores DR, Jaber WA, Brunken RC, Cerqueira MD, et al. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium. Circ Cardiovasc Imaging. 2013;6:363–72. https://doi.org/10.1161/circimaging.112.000138.
Verberne HJ, Acampa W, Anagnostopoulos C, Ballinger J, Bengel F, De Bondt P, et al. EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging. 2015;42:1929–40. https://doi.org/10.1007/s00259-015-3139-x.
Siegrist PT, Gaemperli O, Koepfli P, Schepis T, Namdar M, Valenta I, et al. Repeatability of cold pressor test-induced flow increase assessed with H(2)(15)O and PET. J Nucl Med. 2006;47:1420–6.
Beanlands RS, deKemp R, Scheffel A, Nahmias C, Garnett ES, Coates G, et al. Can nitrogen-13 ammonia kinetic modeling define myocardial viability independent of fluorine-18 fluorodeoxyglucose? J Am Coll Cardiol. 1997;29:537–43.
Hesse B, Tägil K, Cuocolo A, Anagnostopoulos C, Bardiés M, Bax J, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging. 2005;32:855–97. https://doi.org/10.1007/s00259-005-1779-y.
Fallavollita JA, Canty JM. Differential 18F-2-deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion: evidence for chronic stunning in pigs. Circulation. 1999;99:2798–805.
Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146–9.
Camici PG, Dutka DP. Repetitive stunning, hibernation, and heart failure: contribution of PET to establishing a link. Am J Physiol Heart Circ Physiol. 2001;280:H929–36. https://doi.org/10.1152/ajpheart.2001.280.3.H929.
Gewirtz H, Fischman AJ, Abraham S, Gilson M, Strauss HW, Alpert NM. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol. 1994;23:851–9.
Benz DC, Ferro P, Safa N, Messerli M, von Felten E, Huang W, et al. Role of quantitative myocardial blood flow and 13N-ammonia washout for viability assessment in ischemic cardiomyopathy. J Nucl Cardiol. 2019. https://doi.org/10.1007/s12350-019-01684-1.
Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Di Carli G, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011;124:2215–24. https://doi.org/10.1161/circulationaha.111.050427.
Gebhard C, Fiechter M, Herzog BA, Lohmann C, Bengs S, Treyer V, et al. Sex differences in the long-term prognostic value of. Eur J Nucl Med Mol Imaging. 2018;45:1964–74. https://doi.org/10.1007/s00259-018-4046-8.
Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012;126:1858–68. https://doi.org/10.1161/circulationaha.112.120402.
Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Dorbala S, et al. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. JACC Cardiovasc Imaging. 2012;5:1025–34. https://doi.org/10.1016/j.jcmg.2012.06.007.
Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation. 2002;105:186–93.
Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015;131:19–27. https://doi.org/10.1161/CIRCULATIONAHA.114.011939.
Acknowledgements
We thank Verena Weichselbaumer, Martina Vogt, Tania Lagrange, Kevin Frei, Kathrin Amsler, Frederic Koszarski und Bejtulah Salahi for their excellent technical support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The University Hospital Zurich holds a research agreement with GE Healthcare. Dominik C. Benz has received research grants from the Theodor and Ida Herzog-Egli Foundation. Anita Schneider declares that she has no conflict of interest. Wenjie Huang declares that he has no conflict of interest. Michael Messerli declares that he has no conflict of interest. Elia von Felten declares that he has no conflict of interest. Georgios Benetos declares that he has no conflict of interest. Andreas A. Giannopoulos declares that he has no conflict of interest. Tobias A. Fuchs declares that he has no conflict of interest. Christoph Gräni declares that he has no conflict of interest. Catherine Gebhard declares that he has no conflict of interest. Aju P. Pazhenkottil declares that he has no conflict of interest. Oliver Gaemperli declares that he has no conflict of interest. Philipp A. Kaufmann declares that he has no conflict of interest. Ronny R. Buechel declares that he has no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the local research committee (Ethics Committee Zurich, BASEC-Nr. 2016-00177) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was waived for all patients scanned before 2014 due to subsequent use of non-genetic personal health data only. For all patients scanned afterward (after the adoption of a new law in Switzerland), written informed consent was obtained.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Dominik C. Benz and Anita P. von Dahlen share first authorship
This article is part of the Topical Collection on Cardiology
Rights and permissions
About this article
Cite this article
Benz, D.C., von Dahlen, A. ., Huang, W. et al. No differences in rest myocardial blood flow in stunned and hibernating myocardium: insights into the pathophysiology of ischemic cardiomyopathy. Eur J Nucl Med Mol Imaging 46, 2322–2328 (2019). https://doi.org/10.1007/s00259-019-04440-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-019-04440-2